openPR Logo
Press release

Global Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Industry Trends and Forecast 2014 - 2020

01-23-2017 02:11 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Molecular Diagnostic

Researchmoz added Most up-to-date research on "Molecular Diagnostic Market For Group A Streptococcus (GAS) NA Tests - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020" to its huge collection of research reports.

Group A Streptococcus (GAS) is a type of gram-positive B-hemolytic Streptococcus bacteria. These bacteria are capable of causing a wide range of both non-invasive and invasive infections. GAS infection might spread through direct contact with skin sores or mucus of a infected person. Despite the emergence of wide range effective and safe antibiotics as a treatment regimen for GAS, infection caused by GAS is increasing significantly across the world. However, with the use of advance molecular diagnosis kits and technologies, the progression of the infections can be slowed down to a significantly, which will ultimately reduce the recovery time of the patient. Currently, molecular diagnostic market for GAS NA test is a lucrative market venture due to high patient preference and increasing base of patients suffering from Streptococcal infections, which makes this industry a highly profitable and attractive market.

Some of the molecular diagnostic techniques generally used for group A Streptococcus (GAS) NA tests are as follows:

- Rapid antigen testing techniques
- Rapid chromatographic immunoassay testing techniques
- In vitro diagnostic testing techniques
- RT-PCR based techniques

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=209074

In the geographical analysis, North America is the largest market for molecular diagnostic kits for group A Streptococcus tests owing to the high incidence rate of Streptococcal infections and diseases. According to the Centers for Disease Control and Prevention (CDC), each year, nearly 11,000 people suffer from invasive GAS infections and approximately 10 million people suffer from non-invasive GAS infections, in the U.S.

However, other regions such as South East Asia, Latin America and Middle East are expected to be the promising markets in the near future. Owing to the rising disposable income among population and high adoption rate for advanced molecular diagnostics kits and technologies, these regions are expected to be the potential market in the near future.

The overall molecular diagnostic market for group A Streptococcus (GAS) NA tests is experiencing an admirable growth; due to the increasing incidence rate of group A Streptococcus infections, such as pharyngitis, tonsillitis and fever. Moreover, large base of patients affected from streptococcal infections including both geriatric population and youth is expected to drive the growth of various molecular diagnostic kits that are used for group A Streptococcus tests. It has also been estimated that, this market is shows potential to be a lucrative and expanding field due the increasing adoption rate for advanced diagnostic technologies and services. Expected technological breakthroughs will generate abundant opportunities for molecular diagnostic kits that could be used for detecting targeted Streptococcal bacteria, which causes the infections. For instance, Japan based Otsuka Pharmaceutical Co., Ltd. launched a rapid diagnostic test kit, "QuickNavi Strep A" for rapid detection of beta-hemolytic group A Streptococcus on 14 April 2014.

However, rise in overall healthcare expenditure, stringent reimbursement policies and high development costs are some of the market-restraining factors that might hinder the growth of molecular diagnostic kits market for group A Streptococcus (GAS) NA tests in future.

Currently, the molecular diagnostic market for Group A Streptococcus (GAS) NA tests is a highly fragmented market owing to the involvement of many established and emerging players in the market. Some of the companies involved with development and commercialization of amplification and detection platforms for performing these tests are Abbott Laboratories, Applied Biosystems, Bio-Rad Laboratories, Inc., bioMérieux, Cepheid, Inc., Digene Corporation, Otsuka Pharmaceutical Co., Ltd., Qiagen, Roche Diagnostics Corporation, Siemens AG and Stratagene Corporation (Agilent Technologies Inc.)

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

- North America
- Asia Pacific
- Europe
- Rest of the World

This report provides comprehensive analysis of

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=209074

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Industry Trends and Forecast 2014 - 2020 here

News-ID: 419622 • Views:

More Releases from Molecular Diagnostic

Agilent Technologies, bioMérieux, Novartis Company Profiles in Molecular Diagnostics Market| Key Players: Bio-Rad Laboratories, Alere Inc., QIAGEN, Danaher Corporation, Analytik Jena AG, BD, Cepheid, Biocartis, Genomic Health
Agilent Technologies, bioMérieux, Novartis Company Profiles in Molecular Diagno …
The Molecular Diagnostics Market size is set to exceed USD 12.5 billion by 2024; according to a new research report by Global Market Insights. Technological advancements and consequent development of superior molecular diagnostic techniques for early and accurate diagnosis of chronic diseases will drive molecular diagnostics market growth over the forecast period. Consumers in developed economies are far more informed about the availability of these advanced technologies and plays crucial
Molecular Diagnostic Market by Products Test Analysis in Polymerase Chain Reacti …
According to a new market report published by Transparency Market Research “Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023”, the Europe molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products market was valued at US$ 8.3 Mn in 2014 and is projected to expand at a CAGR

More Releases for Strep

Strep Throat Treatment Market 2022- Key Strategy, Revenue, Opportunity and Key T …
The Strep Throat Treatment Market report presents a cautious assessment of the genuine scene, thinking about the slices of the pie of the principal associations. It furthermore gives information. These outfits the key market individuals with principal business knowledge and help them with understanding the destiny of the Strep Throat Treatment market. The examination joins the figure, a layout of the genuine plan, the bits of the general business of
Treatment for Strep Throat Market Witness an Outstanding Growth and Strong Reven …
The global strep throat treatment market is predicted to expand because of the rising frequency of bacterial infections and the transfer of infectious diseases in developing nations due to a lack of sanitation. The overall growth of the strep throat treatment market is likely to be boosted by an increase in the number of cases of bacterial infection. The expansion of the strep throat treatment market is also projected to
Streptococci Testing Market to make Great Impact in near Future by 2024
Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood infections (septicemia), pneumonia,
Streptococci Testing Market is Anticipated to Show the Robust Growth by 2024
Streptococci Testing Market: Overview Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood
Streptococci Testing Market : Evolving Technology And Industry Analysis – 2024 …
Streptococci Testing Market: Overview Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood
Streptococci Testing Market - Global Industry Analysis, Size, Share, Growth, Tre …
Streptococci Testing Market: Key Segments The global streptococci testing market can be segmented based in tests type, end users and geography. Antibody tests include the antistreptolysin O titer (ASO), anti-DNase-B (ADB) test and Streptozyme. ASO test helps in determining a kidney disease glomerulonephritis, scarlet fever or rheumatic fever. ADB test is performed to determine a previous infection of a group A beta-hemolytic Streptococcus. Streptozyme is a screening test used to detect